Glaucoma Therapeutics Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Aug 2018| TMR870A| Transparency

Report Highlights

Glaucoma Therapeutics Market: Scope and Methodology

This report analyzes the current and future prospects of the global glaucoma therapeutics market. The report comprises a comprehensive executive summary, including a market snapshot that provides overall information of various segments. The research is a combination of primary and secondary research. Primary research formed the bulk of the research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2016 to 2026, considering the macro and micro environmental factors. Growth rates for each segment within the global glaucoma therapeutics market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

A detailed qualitative analysis of factors responsible for driving and restraining the market and future opportunities has been provided in the overview section. The report also provides insights into the key trends of the glaucoma therapeutics market such as growth in geriatric and diabetic populations, increase in health care spending, and innovative drug combinations. Key market indicators influencing the global glaucoma therapeutics market, including cost constraints and regulatory landscape, have been taken into consideration. The report also includes market attractiveness analysis of the major segments that provides a thorough analysis of the overall competitive scenario in the global glaucoma therapeutics market.

Market revenue in terms of US$ Mn for the period between 2016 and 2026 along with the compound annual growth rate (CAGR %) from 2018 to 2026 are provided for all the segments, considering 2017 as the base year. The year-on-year growth of the global glaucoma therapeutics market for each segment is also reflected. Additionally, market-related factors such as favorable reimbursement scenario, gene replacement therapy, side effects associated with glaucoma drugs, and historical year-on-year growth have been taken into consideration while estimating the market size.

Glaucoma Therapeutics Market: Segmentation

Based on drug class, the global glaucoma therapeutics market has been segmented into prostaglandins, beta blockers, alpha agonists, carbonic anhydrase inhibitors, combination medications, and cholinergics. In terms of end-user, the market has been classified into hospitals, ophthalmic clinics, and ambulatory surgical centers. The hospitals segment is expected to dominate the market during the forecast period.

In terms of region, the global glaucoma therapeutics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Additionally, the regions have been divided into major countries/sub-regions. These include the U.S., Canada, the U.K., Germany, France, Italy, Spain, China, Australia, Japan, India, Brazil, GCC Countries, South Africa, and Mexico.

Glaucoma Therapeutics Market: Competitive Landscape

The report also profiles major players in the global glaucoma therapeutics market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Allergan plc, Merck & Co., Inc., Novartis AG, Pfizer, Inc., Santen Pharmaceuticals Co. Ltd., Valeant Pharmaceuticals International, Inc., and Aerie Pharmaceuticals, Inc.

The global glaucoma therapeutics Market has been segmented as follows:

Global Glaucoma Therapeutics Market, by Drug Class
Prostaglandins
Beta Blockers
Alpha Agonists
Carbonic Anhydrase Inhibitors
Combination Medications
Cholinergics

Global Glaucoma therapeutics Market, by End-user
Hospitals
Ophthalmic Clinics
Ambulatory Surgical Centers

Global Glaucoma therapeutics Market, by Geography
North America
U.S.
Canada
Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
Asia Pacific
Australia & New Zealand
Japan
China
India
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of Middle East & Africa

  • Table 1 : Global Glaucoma Therapeutics Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 2 : Global Glaucoma Therapeutics Market Size (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 3 : Global Glaucoma Therapeutics Market Size (US$ Mn) Forecast, by Region, 2016–2026
  • Table 4 : North America Glaucoma Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 5 : North America Glaucoma Therapeutics Market Forecast, by End-user, 2016–2026
  • Table 6 : North America Glaucoma Therapeutics Market Value (US$ Mn) Forecast, by Country, 2016–2026
  • Table 7 : U.S. Glaucoma Therapeutics Market Forecast, by Drug Class, 2016–2026
  • Table 8 : U.S. Glaucoma Therapeutics Market Forecast, by End-user, 2016–2026
  • Table 9 : Canada Glaucoma Therapeutics Market Forecast, by Drug Class, 2016–2026
  • Table 10 : Canada Glaucoma Therapeutics Market Forecast, by End-user, 2016–2026
  • Table 11 : Europe Glaucoma Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 12 : Europe Glaucoma Therapeutics Market Forecast, by End-user, 2016–2026
  • Table 13 : Europe Glaucoma Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 14 : U.K. Glaucoma Therapeutics Market Forecast, by Drug Class, 2016–2026
  • Table 15 : U.K. Glaucoma Therapeutics Market Forecast, by End-user, 2016–2026
  • Table 16 : Germany Glaucoma Therapeutics Market Forecast, by Drug Class, 2016–2026
  • Table 17 : Germany Glaucoma Therapeutics Market Forecast, by End-user, 2016–2026
  • Table 18 : France Glaucoma Therapeutics Market Forecast, by Drug Class, 2016–2026
  • Table 19 : France Glaucoma Therapeutics Market Forecast, by End-user, 2016–2026
  • Table 20 : Spain Glaucoma Therapeutics Market Forecast, by Drug Class, 2016–2026
  • Table 21 : Spain Glaucoma Therapeutics Market Forecast, by End-user, 2016–2026
  • Table 22 : Italy Glaucoma Therapeutics Market Forecast, by Drug Class, 2016–2026
  • Table 23 : Italy Glaucoma Therapeutics Market Forecast, by End-user, 2016–2026
  • Table 24 : Rest of Europe Glaucoma Therapeutics Market Forecast, by Drug Class, 2016–2026
  • Table 25 : Rest of Europe Glaucoma Therapeutics Market Forecast, by End-user, 2016–2026
  • Table 26 : Asia Pacific Glaucoma Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 27 : Asia Pacific Glaucoma Therapeutics Market Forecast, by End-user, 2016–2026
  • Table 28 : Asia Pacific Glaucoma Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 29 : Japan Glaucoma Therapeutics Market Forecast, by Drug Class, 2016–2026
  • Table 30 : Japan Glaucoma Therapeutics Market Forecast, by End-user, 2016–2026
  • Table 31 : China Glaucoma Therapeutics Market Forecast, by Drug Class, 2016–2026
  • Table 32 : China Glaucoma Therapeutics Market Forecast, by End-user, 2016–2026
  • Table 33 : India Glaucoma Therapeutics Market Forecast, by Drug Class, 2016–2026
  • Table 34 : India Glaucoma Therapeutics Market Forecast, by End-user, 2016–2026
  • Table 35 : Australia & New Zealand Glaucoma Therapeutics Market Forecast, by Drug Class, 2016–2026
  • Table 36 : Australia & New Zealand Glaucoma Therapeutics Market Forecast, by End-user, 2016–2026
  • Table 37 : Rest of APAC Glaucoma Therapeutics Market Forecast, by Drug Class, 2016–2026
  • Table 38 : Rest of APAC Glaucoma Therapeutics Market Forecast, by End-user, 2016–2026
  • Table 39 : Latin America Glaucoma Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 40 : Latin America Glaucoma Therapeutics Market Forecast, by End-user, 2016–2026
  • Table 41 : Latin America Glaucoma Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 42 : Brazil Glaucoma Therapeutics Market Forecast, by Drug Class, 2016–2026
  • Table 43 : Brazil Glaucoma Therapeutics Market Forecast, by End-user, 2016–2026
  • Table 44 : Mexico Glaucoma Therapeutics Market Forecast, by Drug Class, 2016–2026
  • Table 45 : Mexico Glaucoma Therapeutics Market Forecast, by End-user, 2016–2026
  • Table 46 : Rest of LATAM Glaucoma Therapeutics Market Forecast, by Drug Class, 2016–2026
  • Table 47 : Rest of LATAM Glaucoma Therapeutics Market Forecast, by End-user, 2016–2026
  • Table 48 : Middle East & Africa Glaucoma Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 49 : Middle East & Africa Glaucoma Therapeutics Market Forecast, by End-user, 2016–2026
  • Table 50 : Middle East & Africa Glaucoma Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 51 : GCC Countries Glaucoma Therapeutics Market Forecast, by Drug Class, 2016–2026
  • Table 52 : GCC Countries Glaucoma Therapeutics Market Forecast, by End-user, 2016–2026
  • Table 53 : South Africa Glaucoma Therapeutics Market Forecast, by Drug Class, 2016–2026
  • Table 54 : South Africa Glaucoma Therapeutics Market Forecast, by End-user, 2016–2026
  • Table 55 : Rest of MEA Glaucoma Therapeutics Market Forecast, by Drug Class, 2016–2026
  • Table 56 : Rest of MEA Glaucoma Therapeutics Market Forecast, by End-user, 2016–2026
  • Figure 1 : Global Glaucoma Therapeutics Market Snapshot
  • Figure 2 : Global Glaucoma Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2026
  • Figure 3 : Market Value Share, by Drug Class (2017)
  • Figure 4 : Market Value Share, by End-user (2017)
  • Figure 5 : Market Value Share, by Region (2017)
  • Figure 6 : Global Glaucoma Therapeutics Market Value Share Analysis, by Drug Class, 2017 and 2026
  • Figure 7 : Global Prostaglandins Market Revenue (US$ Mn), 2016–2026
  • Figure 8 : Global Beta Blockers Market Revenue (US$ Mn), 2016–2026
  • Figure 9 : Global Alpha Agonist Market, Revenue (US$ Mn), 2016–2026
  • Figure 10 : Global Carbonic Anhydrase Inhibitor (CAI) Market, Revenue (US$ Mn), 2016–2026
  • Figure 11 : Global Combination Medications Market, Revenue (US$ Mn), 2016–2026
  • Figure 12 : Global Cholinergic Market, Revenue (US$ Mn), 2016–2026
  • Figure 13 : Global Glaucoma Therapeutics Market Attractiveness Analysis, by Drug Class
  • Figure 14 : Global Glaucoma Therapeutics Market Value Share Analysis, by End-user, 2017 and 2026
  • Figure 15 : Global Hospitals Market Revenue (US$ Mn), 2016–2026
  • Figure 16 : Global Ophthalmic Clinics Market Revenue (US$ Mn), 2016–2026
  • Figure 17 : Global Ambulatory Surgical Centers Market Revenue (US$ Mn), 2016–2026
  • Figure 18 : Global Glaucoma Therapeutics Market Attractiveness Analysis, by End-user
  • Figure 19 : Global Glaucoma Therapeutics Market Value Share Analysis, by Region, 2017 and 2026
  • Figure 20 : Global Glaucoma Therapeutics Market Attractiveness Analysis, by Region, 2018–2026
  • Figure 21 : North America Glaucoma Therapeutics Market Value (US$ Mn) Forecast, 2016–2026
  • Figure 22 : North America Glaucoma Therapeutics Glaucoma Therapeutics Market Attractiveness Analysis, by Country
  • Figure 23 : North America Glaucoma Therapeutics Market Value Share Analysis, by Drug Class, 2017 and 2026
  • Figure 24 : North America Glaucoma Therapeutics Market Value Share Analysis, by End-user, 2017 and 2026
  • Figure 25 : North America Glaucoma Therapeutics Market, by Country, 2017 and 2026
  • Figure 26 : North America Glaucoma Therapeutics Glaucoma Therapeutics Market Attractiveness Analysis, by Drug Class
  • Figure 27 : North America Glaucoma Therapeutics Glaucoma Therapeutics Market Attractiveness Analysis, by End-user
  • Figure 28 : Europe Glaucoma Therapeutics Market Value (US$ Mn) Forecast, 2016–2026
  • Figure 29 : Europe Glaucoma Therapeutics Glaucoma Therapeutics Market Attractiveness Analysis, by Country/Sub-Region
  • Figure 30 : Europe Glaucoma Therapeutics Market Value Share Analysis, by Drug Class, 2017 and 2026
  • Figure 31 : Europe Glaucoma Therapeutics Market Value Share Analysis, by End-user, 2017 and 2026
  • Figure 32 : Europe Glaucoma Therapeutics Market, by Country/Sub-region
  • Figure 33 : Europe Glaucoma Therapeutics Glaucoma Therapeutics Market Attractiveness Analysis, by Drug Class
  • Figure 34 : Europe Glaucoma Therapeutics Glaucoma Therapeutics Market Attractiveness Analysis, by End-user
  • Figure 35 : Asia Pacific Glaucoma Therapeutics Market Value (US$ Mn) Forecast, 2016–2026
  • Figure 36 : Asia Pacific Glaucoma Therapeutics Glaucoma Therapeutics Market Attractiveness Analysis, by Country/Sub-Region
  • Figure 37 : Asia Pacific Glaucoma Therapeutics Market Value Share Analysis, by Drug Class, 2017 and 2026
  • Figure 38 : Asia Pacific Glaucoma Therapeutics Market Value Share Analysis, by End-user, 2017 and 2026
  • Figure 39 : Asia Pacific Glaucoma Therapeutics Market, by Country/Sub-region
  • Figure 40 : Asia Pacific Glaucoma Therapeutics Glaucoma Therapeutics Market Attractiveness Analysis, by Drug Class
  • Figure 41 : Asia Pacific Glaucoma Therapeutics Glaucoma Therapeutics Market Attractiveness Analysis, by End-user
  • Figure 42 : Latin America Glaucoma Therapeutics Market Value (US$ Mn) Forecast, 2016–2026
  • Figure 43 : Latin America Glaucoma Therapeutics Glaucoma Therapeutics Market Attractiveness Analysis, by Country/Sub-region
  • Figure 44 : Latin America Glaucoma Therapeutics Market Value Share Analysis, by Drug Class, 2017 and 2026
  • Figure 45 : Latin America Glaucoma Therapeutics Market Value Share Analysis, by End-user, 2017 and 2026
  • Figure 46 : North America Glaucoma Therapeutics Market, by Country/Sub-region
  • Figure 47 : Latin America Glaucoma Therapeutics Glaucoma Therapeutics Market Attractiveness Analysis, by Drug Class
  • Figure 48 : Latin America Glaucoma Therapeutics Glaucoma Therapeutics Market Attractiveness Analysis, by End-user
  • Figure 49 : Middle East & Africa Glaucoma Therapeutics Market Value (US$ Mn) Forecast, 2016–2026
  • Figure 50 : Middle East & Africa Glaucoma Therapeutics Glaucoma Therapeutics Market Attractiveness Analysis, by Country/Sub-region
  • Figure 51 : Middle East & Africa Glaucoma Therapeutics Market Value Share Analysis, by Drug Class, 2017 and 2026
  • Figure 52 : Middle East & Africa Glaucoma Therapeutics Market Value Share Analysis, by End-user, 2017 and 2026
  • Figure 53 : Middle East & Africa Glaucoma Therapeutics Market, by Country/Sub-region
  • Figure 54 : Middle East & Africa Glaucoma Therapeutics Glaucoma Therapeutics Market Attractiveness Analysis, by Drug Class
  • Figure 55 : Middle East & Africa Glaucoma Therapeutics Glaucoma Therapeutics Market Attractiveness Analysis, by End-user
  • Figure 56 : Global Glaucoma Therapeutics Market Share Analysis, by Company (2017)

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report